Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

We chatted with dermatologists to find out what LED light therapy devices can and cannot do for your skin when it comes to ...

The scary condition sufferers say ‘traps you in your own half-alive corpse’ — it’s caused by a medication taken by millions ...

On social media, shower rituals have become more elaborate and product-heavy than they need to be, according to health ...

EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare gene ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

When it comes to your baby’s delicate skin, especially on their face, finding the right moisturiser isn’t just a nice-to-have, it’s a must. Baby skin is thinner and more sensitive than adult skin, ...

Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.